Takeda Pharmaceutical (TAK) Long-Term Investments: 2018-2025

Historic Long-Term Investments for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $2.3 billion.

  • Takeda Pharmaceutical's Long-Term Investments rose 0.09% to $2.3 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 billion, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.3 billion for FY2025, which is 2.45% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Long-Term Investments stood at $2.3 billion for FY2025, which was down 2.45% from $2.4 billion recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Investments peaked at $2.4 billion during FY2024, and registered a low of $2.1 billion during FY2023.
  • Moreover, its 3-year median value for Long-Term Investments was $2.3 billion (2025), whereas its average is $2.2 billion.
  • Its Long-Term Investments has fluctuated over the past 5 years, first dropped by 7.73% in 2021, then rose by 14.14% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Investments (Yearly) stood at $2.2 billion in 2021, then declined by 6.51% to $2.1 billion in 2022, then declined by 0.48% to $2.1 billion in 2023, then rose by 14.14% to $2.4 billion in 2024, then fell by 2.45% to $2.3 billion in 2025.